4 insiders reported 38 Form 4 transactions for Terns Pharmaceuticals, Inc. (TERN) over the past 18 months (most recent 2026-05-05). Recent activity: Burroughs Amy L. (Chief Executive Officer) Sell 146,614 shares, Burroughs Amy L. (Chief Executive Officer) Sell 8,319 shares, Burroughs Amy L. (Chief Executive Officer) Sell 150,000 shares, Gengos Andrew (Chief Financial Officer) Sell 40,503 shares, Gengos Andrew (Chief Financial Officer) Sell 68,750 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-05 | Burroughs Amy L. | Chief Executive Officer | Sell | 146,614 | $7.8M |
| 2026-05-05 | Burroughs Amy L. | Chief Executive Officer | Sell | 8,319 | $440,907 |
| 2026-05-05 | Burroughs Amy L. | Chief Executive Officer | Sell | 150,000 | $8.0M |
| 2026-05-05 | Gengos Andrew | Chief Financial Officer | Sell | 40,503 | $2.1M |
| 2026-05-05 | Gengos Andrew | Chief Financial Officer | Sell | 68,750 | $3.6M |
| 2026-05-05 | Kuriakose Emil | Chief Medical Officer | Sell | 24,562 | $1.3M |
| 2026-05-05 | Kuriakose Emil | Chief Medical Officer | Sell | 81,953 | $4.3M |
| 2026-04-02 | Kuriakose Emil | Chief Medical Officer | Sell | 942 | $49,690 |
| 2026-03-17 | Burroughs Amy L. | Chief Executive Officer | Buy | 14,583 | $67,665 |
| 2026-03-17 | Burroughs Amy L. | Chief Executive Officer | Sell | 11,813 | $550,131 |
| 2026-03-17 | Burroughs Amy L. | Chief Executive Officer | Sell | 2,770 | $131,021 |
| 2026-02-18 | Burroughs Amy L. | Chief Executive Officer | Sell | 2,341 | $89,122 |
| 2026-02-18 | Burroughs Amy L. | Chief Executive Officer | Buy | 14,583 | $67,665 |
| 2026-02-18 | Burroughs Amy L. | Chief Executive Officer | Sell | 8,159 | $319,996 |
| 2026-02-18 | Burroughs Amy L. | Chief Executive Officer | Sell | 4,083 | $162,503 |
| 2026-01-16 | Gengos Andrew | Chief Financial Officer | Buy | 68,750 | $0 |
| 2026-01-16 | Burroughs Amy L. | Chief Executive Officer | Buy | 150,000 | $0 |
| 2026-01-16 | Burroughs Amy L. | Chief Executive Officer | Buy | 27,083 | $125,665 |
| 2026-01-16 | Burroughs Amy L. | Chief Executive Officer | Buy | 27,083 | $125,665 |
| 2026-01-16 | Burroughs Amy L. | Chief Executive Officer | Buy | 14,583 | $67,665 |
| 2026-01-16 | Burroughs Amy L. | Chief Executive Officer | Sell | 61,228 | $2.3M |
| 2026-01-16 | Burroughs Amy L. | Chief Executive Officer | Sell | 7,521 | $282,263 |
| 2026-01-16 | Kuriakose Emil | Chief Medical Officer | Buy | 56,250 | $0 |
| 2026-01-06 | Burroughs Amy L. | Chief Executive Officer | Buy | 21,551 | $99,997 |
| 2026-01-06 | Burroughs Amy L. | Chief Executive Officer | Buy | 150,000 | $0 |
Source: SEC Form 4 filings · as of 2026-05-05